Trial Profile
A Phase 4, Randomized-withdrawal, Double-blind, Placebo controlled, Parallel-group Study to Investigate the Clinical Benefit of Midodrine Hydrochloride in Male and Female Subjects with Symptomatic Orthostatic Hypotension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jun 2021
Price :
$35
*
At a glance
- Drugs Midodrine (Primary)
- Indications Orthostatic hypotension
- Focus Therapeutic Use
- 11 Nov 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 25 Jun 2013 New trial record